Company Filing History:
2 out of 379 
2 out of 12 Years Active: 2018
Title: Kevin Sean Kimbro: Innovator in Genetic Research
Introduction
Kevin Sean Kimbro is a notable inventor based in Durham, NC (US), recognized for his contributions to genetic research, particularly in the field of cancer risk assessment. With a total of two patents to his name, Kimbro's work focuses on identifying genetic predispositions to prostate and breast cancer.
Latest Patents
Kimbro's latest patents include "Genetic determinants of prostate and breast cancer risk," which describes methods for determining if a subject has a genetic predisposition to developing prostate cancer (PCa) or aggressive PCa, as well as breast cancer (BrCa). Another significant patent is "Genetic determinants of prostate cancer risk," which outlines methods for assessing the genetic risk of developing prostate cancer, particularly for American or Caribbean subjects of African descent.
Career Highlights
Throughout his career, Kimbro has worked with esteemed institutions such as the University of Louisville Research Foundation, Inc. and North Carolina Central University. His research has significantly contributed to the understanding of genetic factors influencing cancer risk.
Collaborations
Kimbro has collaborated with various professionals in his field, including La Creis Renee Kidd, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Kevin Sean Kimbro's innovative work in genetic research has paved the way for advancements in cancer risk assessment, making him a significant figure in the field. His contributions continue to influence the understanding of genetic predispositions to cancer.